| |
| |
|
| Insider
Information: |
Smith Ian F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
267,823 |
|
|
Indirect Shares
|
5,306 |
|
|
| Direct
Value |
$22,658,153 |
|
|
|
Indirect Value
|
$2,507,138 |
|
|
| Total
Shares |
273,129 |
|
|
| Total
Value |
$25,165,291 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
|
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2007-09-05 |
4 |
OE |
$26.20 |
$2,382,235 |
D/D |
90,925 |
171,039 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2007-09-05 |
4 |
AS |
$40.00 |
$3,637,000 |
D/D |
(90,925) |
80,114 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-02-07 |
4 |
A |
$0.01 |
$97 |
D/D |
9,667 |
90,031 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-05-13 |
4 |
AS |
$26.99 |
$155,442 |
D/D |
(5,730) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-05-20 |
4 |
AS |
$27.47 |
$25,691 |
D/D |
(930) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-07-09 |
4 |
OE |
$9.07 |
$1,299,292 |
D/D |
81,436 |
165,737 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-07-09 |
4 |
AS |
$35.00 |
$2,850,260 |
D/D |
(81,436) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-11-18 |
4 |
AS |
$26.18 |
$419 |
D/D |
(16) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-02-04 |
4 |
AS |
$33.51 |
$95,788 |
D/D |
(2,850) |
81,451 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
93,535 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-02-06 |
4 |
AS |
$35.00 |
$1,442,420 |
D/D |
(41,212) |
93,535 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-02-06 |
4 |
OE |
$10.41 |
$482,638 |
D/D |
41,212 |
134,747 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-05-07 |
4 |
AS |
$28.90 |
$939,250 |
D/D |
(32,500) |
61,035 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-05-18 |
4 |
AS |
$28.44 |
$26,307 |
D/D |
(925) |
61,035 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2010-02-04 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
73,119 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2010-04-05 |
4 |
AS |
$40.75 |
$743,362 |
D/D |
(18,242) |
54,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2010-05-18 |
4 |
AS |
$37.68 |
$29,164 |
D/D |
(774) |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2010-11-15 |
4 |
AS |
$34.47 |
$2,654 |
D/D |
(77) |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-01-21 |
4 |
AS |
$39.93 |
$241,257 |
D/D |
(6,042) |
33,835 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-01-25 |
4 |
AS |
$40.71 |
$245,970 |
D/D |
(6,042) |
27,793 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-02-03 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-05-17 |
4 |
AS |
$56.58 |
$40,337 |
D/D |
(709) |
39,877 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-05-25 |
4 |
AS |
$55.52 |
$676,106 |
D/D |
(12,084) |
27,793 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2011-11-15 |
4 |
AS |
$29.75 |
$595 |
D/D |
(20) |
27,793 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2012-01-19 |
4 |
AS |
$37.00 |
$223,554 |
D/D |
(6,042) |
21,751 |
0 |
- |
|
128 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
